Dammam: Almarai Company signed an agreement with the Health Endowments Association to implement the "Beautiful Eyes" initiative, a unique health initiative aimed at supporting cataract surgeries for patients in need. While cataracts are a common eye condition, untreated cataracts can lead to partial or complete vision loss, negatively impacting the ability of those affected to function normally in their daily lives. This initiative is one of Almarai Company's healthcare initiatives, which falls under the company's corporate social responsibility .

The agreement was signed by Mr. Abdulrahman Al-Afaleq, Head of Corporate Communications at Almarai Company, and Mr. Muayyad Al-Hadban, CEO of the Health Endowments Association, at the association's headquarters in Dammam. The support will be directed towards the most vulnerable and low-income patients, enabling them to undergo the necessary surgeries to regain their sight and improve their daily lives. The "Beautiful Eyes" initiative embodies Almarai's commitment to making a positive social impact and supporting healthcare initiatives in the community .

Cataract surgery is one of the most common eye surgeries in the Kingdom. The disease arises from various causes, most notably aging, diabetes, and high blood pressure, which can lead to a loss of elasticity in the eye's lens, causing it to thicken and become less transparent. This condition can result in partial or complete vision loss, significantly impacting the quality of life of those affected. Surgical intervention is the only available treatment for these cases. The success rate of cataract surgery is high, exceeding 95 %.

-I finish-

#Company Data

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.